Workflow
i99 智健
icon
Search documents
华大基因徐茜入选2025 ALB China 十五佳总法律顾问,以法务智慧护航生命科学创新
Jing Ji Guan Cha Wang· 2025-10-30 03:50
Core Insights - The article highlights the recognition of Xu Qian, the Vice President and General Counsel of BGI Genomics, as one of the "Top 15 General Counsels in China" by Asian Legal Business, reflecting her outstanding contributions in legal exploration, technological innovation, and global compliance [1][4]. Group 1: Recognition and Awards - The "Top 15 General Counsels in China" list has been published for ten consecutive years, aiming to identify outstanding general counsels who demonstrate foresight, leadership, and significant influence in complex environments [4]. - Xu Qian's inclusion in the list is a testament to her exceptional legal skills and strategic understanding of business, which have redefined the role of general counsel and expanded its value boundaries [4]. Group 2: AI and Legal Compliance - BGI Genomics is integrating AI technology into its research platforms, data analysis, and clinical applications, enhancing diagnostic efficiency while ensuring data sovereignty and compliance [5]. - The company has launched innovative products, such as the "Hereditary Tumor Variation Knowledge Base," addressing gaps in domestic tumor precision diagnosis data products, supported by a robust legal compliance team [5]. Group 3: Globalization and Compliance Strategy - BGI Genomics is advancing its globalization strategy by establishing precision medicine laboratories and joint ventures in key overseas markets, promoting Chinese technology and standards internationally [6]. - Under Xu Qian's leadership, the company has developed an international compliance system, becoming the first in China to obtain ISO37301 compliance management certification, which enhances its global strategy and sets a positive example for industry compliance standards [6]. Group 4: Role Evolution of Legal Team - Xu Qian has transformed the legal team's role from risk managers to drivers of technological innovation and global strategy, emphasizing the critical value of legal expertise in the high-quality development of the life sciences sector [7]. - The legal team is expected to continue its focus on cutting-edge legal issues, providing strong legal support for corporate innovation and industry compliance upgrades [7].